Reply to ‘Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients’

被引：0
|
作者：
S Kumar
M A Gertz
机构：
[1] Mayo Clinic,Division of Hematology
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1281 / 1282
页数：1
相关论文
共 50 条
  • [41] OPTIMIZATION OF REGIMES OF MOBILIZATION OF BLOOD HEMOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA
    Pokrovskaya, O. S.
    Mendeleeva, L. P.
    Urnova, E. S.
    Gaponova, T. V.
    Gribanova, E. O.
    Alekseeva, I. V.
    Drokov, M. Yu.
    Kalinin, N. N.
    Gretsov, E. M.
    Klyasova, G. A.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (07) : 50 - 57
  • [42] Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
    N Raje
    R Powles
    C Horton
    B Millar
    V Shepherd
    G Middleton
    S Kulkarni
    T Eisen
    J Mehta
    S Singhal
    J Treleaven
    British Journal of Cancer, 1997, 75 : 1684 - 1689
  • [43] Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
    Raje, N
    Powles, R
    Horton, C
    Millar, B
    Shepherd, V
    Middleton, G
    Kulkarni, S
    Eisen, T
    Mehta, J
    Singhal, S
    Treleaven, J
    BRITISH JOURNAL OF CANCER, 1997, 75 (11) : 1684 - 1689
  • [44] INITIAL MOBILIZATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS WITH GRANULOCYTE COLONY-STIMULATING FACTOR AND PLERIXAFOR IN PATIENTS WITH MULTIPLE MYELOMA: A PROSPECTIVE COMPARISON IN LENALIDOMIDE- AND NON-LENALIDOMIDE-TREATED PATIENTS
    Anwer, F.
    Green, M. R.
    Yeager, A. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S201 - S201
  • [45] PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE
    Micallef, I. N. N.
    Tarantolo, S. R.
    McSweeney, P. A.
    Kjein, L. M.
    Calandra, G.
    Huebner, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 292 - 292
  • [46] PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE
    Tarantolo, S. R.
    McSweeney, P. A.
    Micallef, I. N. M.
    Klein, L. M.
    Calandra, G.
    Huebner, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 37 - 37
  • [47] MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS WITH CHEMOTHERAPY AND CYTOKINES IN MULTIPLE-MYELOMA
    HENON, PR
    BECKER, M
    SOVALAT, H
    EISENMANN, JC
    DONATINI, B
    SKLENAR, I
    STEM CELLS, 1995, 13 : 148 - 155
  • [48] Influence of Prior Lenalidomide Exposure On Peripheral Blood Progenitor Cell Mobilization for Autologous Stem Cell Transplant in 144 Consecutive Patients with Multiple Myeloma
    Valent, Jason
    Tageja, Nishant
    Zonder, Jeffrey A.
    Manasa, Richard
    Abrams, Judith
    Avila, Tomoko
    Abidi, Muneer H.
    BLOOD, 2009, 114 (22) : 1248 - 1248
  • [49] Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.
    Witzig, TE
    Gertz, MA
    Lust, JA
    Kyle, RA
    OFallon, WM
    Greipp, PR
    BLOOD, 1995, 86 (10) : 217 - 217
  • [50] Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
    Divaya Bhutani
    Jeffrey Zonder
    Jason Valent
    Nishant Tageja
    Lois Ayash
    Abhinav Deol
    Zaid Al-Kadhimi
    Judith Abrams
    Lawrence Lum
    Voravit Ratanatharathorn
    Joseph Uberti
    Muneer H. Abidi
    Supportive Care in Cancer, 2013, 21 : 2437 - 2442
12345